Prognostic value of cell cycle and apoptosis regulatory proteins in mismatch repair-proficient colorectal cancer: a tissue microarray-based approach.
暂无分享,去创建一个
G. Sauter | L. Terracciano | I. Zlobec | A. Lugli | N. Willi | L. Tornillo | F. Lehmann | R. Maurer | H. Spichtin | K. Glatz | Dimitra Stoios
[1] H. Stein,et al. Prognostic Value of Multimarker Analysis in Stage III Colorectal Cancer: One Step Forward Towards an Individualized Therapy Decision , 2005, Oncology Research and Treatment.
[2] F. Bazzoli,et al. High Thymidylate Synthase Expression in Colorectal Cancer with Microsatellite Instability: Implications for Chemotherapeutic Strategies , 2005, Clinical Cancer Research.
[3] D. Lane,et al. P53 abnormalities and outcomes in colorectal cancer: a systematic review , 2005, British Journal of Cancer.
[4] R. Herrmann,et al. Expression of CEACAM6 in resectable colorectal cancer: a factor of independent prognostic significance. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] R. Chetty. p27 Protein and Cancers of the Gastrointestinal Tract and Liver: An Overview , 2003, Journal of clinical gastroenterology.
[6] R. Herrmann,et al. SMAD7 is a prognostic marker in patients with colorectal cancer , 2003, International journal of cancer.
[7] B. Iacopetta. TP53 mutation in colorectal cancer , 2003, Human mutation.
[8] C. Hsieh,et al. Molecular lesions in colorectal cancer: impact on prognosis? , 2003, International Journal of Colorectal Disease.
[9] C. Cordon-Cardo,et al. Tissue microarray molecular profiling of early, node-negative adenocarcinoma of the rectum: a comprehensive analysis. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[10] B. Leggett,et al. Emerging concepts in colorectal neoplasia. , 2002, Gastroenterology.
[11] H. Stein,et al. Analysis of p53/BAX in primary colorectal carcinoma: Low BAX protein expression is a negative prognostic factor in UICC stage III tumors , 2002, International journal of cancer.
[12] H. McLeod,et al. Analysis of key cell‐cycle checkpoint proteins in colorectal tumours , 2002, The Journal of pathology.
[13] G. Peters,et al. Differential expression of cell cycle and apoptosis related proteins in colorectal mucosa, primary colon tumours, and liver metastases. , 2002, Journal of clinical pathology.
[14] U. Manne,et al. Molecular staging of colorectal cancer in African‐American and Caucasian patients using phenotypic expression of p53, Bcl‐2, MUC‐1 AND p27kip‐1 , 2002, International journal of cancer.
[15] R. Houlston,et al. What we could do now: molecular pathology of colorectal cancer , 2001, Molecular pathology : MP.
[16] P. Maxwell,et al. Apoptosis and cell‐cycle regulatory proteins in colorectal carcinoma: relationship to tumour stage and patient survival , 2001, The Journal of pathology.
[17] H. Zhang,et al. Loss of p27 expression predicts poor prognosis in patients with Dukes' B stage or proximal colorectal cancer. , 2001, International journal of oncology.
[18] R. Kolodner,et al. Multiple pathways cooperate in the suppression of genome instability in Saccharomyces cerevisiae , 2001, Nature.
[19] Nandita Ghosh,et al. Molecular markers are predictors of recurrence and survival in patients with Dukes B and Dukes C colorectal adenocarcinoma , 2001, Diseases of the colon and rectum.
[20] S. Wexner,et al. Dukes B Colorectal Cancer: Distinct Genetic Categories and Clinical Outcome Based on Proximal or Distal Tumor Location , 2001 .
[21] R. Kolodner,et al. Suppression of Spontaneous Chromosomal Rearrangements by S Phase Checkpoint Functions in Saccharomyces cerevisiae , 2001, Cell.
[22] H. Weiss,et al. Molecular characterization of colorectal neoplasia in translational research. , 2001, Archives of pathology & laboratory medicine.
[23] A. Giatromanolaki,et al. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse. , 2001, Anticancer research.
[24] P. Cheah,et al. Down‐regulation of p27 is a significant predictor of poor overall survival and may facilitate metastasis in colorectal carcinomas , 2000, International journal of cancer.
[25] J. Nesland,et al. Protein expression of p53, p21 (WAF1/CIP1), bcl-2, Bax, cyclin D1 and pRb in human colon carcinomas , 2000, Virchows Archiv.
[26] H. McLeod,et al. Expression of cell cycle control proteins in primary colorectal tumors does not always predict expression in lymph node metastases. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[27] R. Broll,et al. p53 and Bcl-2 as significant predictors of recurrence and survival in rectal cancer. , 2000, European journal of cancer.
[28] S. Baldus,et al. Prognostic impact of p21/waf1/cip1 in colorectal cancer , 2000, International journal of cancer.
[29] I. D'Agnano,et al. Evaluation of multiple bio‐pathological factors in colorectal adenocarcinomas: Independent prognostic role of p53 and bcl‐2 , 1999, International journal of cancer.
[30] P. Laurent-Puig,et al. Sequence of molecular genetic events in colorectal tumorigenesis. , 1999, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[31] F. Marandino,et al. Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[32] A. Cittadini,et al. Reduced expression and altered subcellular localization of the cyclin‐dependent kinase inhibitor p27Kip1 in human colon cancer , 1999, Molecular carcinogenesis.
[33] E Mahlamäki,et al. Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays. , 1999, Journal of the National Cancer Institute.
[34] Parfrey,et al. bcl‐2 protein expression is associated with better prognosis in colorectal cancer , 1999, Histopathology.
[35] H. Moch,et al. Tissue microarrays for gene amplification surveys in many different tumor types. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[36] G. Landberg,et al. Prognostic significance of p27Kip1 expression in colorectal cancer: a clinico‐pathological characterization , 1999, The Journal of pathology.
[37] J. Cheville,et al. p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. , 1999, The American journal of pathology.
[38] G. Viale,et al. p21WAF1/CIP1 expression in colorectal carcinoma correlates with advanced disease stage and p53 mutations , 1999, The Journal of pathology.
[39] J. Jass,et al. Towards a molecular classification of colorectal cancer , 1999, International Journal of Colorectal Disease.
[40] K. Kinzler,et al. Genetic instabilities in human cancers , 1998, Nature.
[41] M. Loda,et al. Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases. , 1998, The American journal of pathology.
[42] J. Kononen,et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens , 1998, Nature Medicine.
[43] M. Loda,et al. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas , 1997, Nature Medicine.
[44] H. Höfler,et al. EXPRESSION OF bcl‐2 AND p53 IN DE NOVO AND EX‐ADENOMA COLON CARCINOMA: A COMPARATIVE IMMUNOHISTOCHEMICAL STUDY , 1996, The Journal of pathology.
[45] K. Kinzler,et al. Lessons from Hereditary Colorectal Cancer , 1996, Cell.
[46] K. Kinzler,et al. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. , 1995, Cancer research.
[47] C. Cordon-Cardo. Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia. , 1995, The American journal of pathology.
[48] D. Hicks,et al. BCL-2 expression in human colorectal adenomas and carcinomas. , 1994, Oncogene.
[49] J. Trent,et al. WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.
[50] Bert Vogelstein,et al. p53 function and dysfunction , 1992, Cell.
[51] J. Ferlay,et al. Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.